Denovo to Participate in Upcoming Investor Conferences Highlighting its Biomarker Guided Phase 3 Antidepressant - GlobeNewswire

Submitted by Anonymous (not verified) on Wed, 06/03/2026 - 12:00

Denovo to Participate in Upcoming Investor Conferences Highlighting its Biomarker Guided Phase 3 Antidepressant  GlobeNewswire